Previous Close | 24.96 |
1-Year Change | -9.73% |
6-Months Change | -15.73% |
3-Months Change | 26.76% |
Moving Avg (50d) | 28.598 |
Moving Avg (200d) | 27.572 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 2.8B |
Beta (3-Years) | 1.11 |
Revenue Growth (ttm) | 46.99% |
Net Profit Margin (ttm) | -5.43% |
Return On Assets (ttm) | -3.64% |
EPS (ttm) | -1.02 |
PE Ratio (ttm) | -24.47 |
Dividend Yield | % |
Asset Description: | Evolent Health, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-07-25 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
24.461 | 23.712 | 23.213 | 22.464 | 21.216 | 19.968 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Services |
Country: | United States |